Changes in total IgG concentrations were comparable for the three products. Prior to enrollment, IgG levels averaged 115C-72 mg/dl, increasing to 779'399 at 24 hours postinfusion, and were 337+200 after 3 weeks. No differences among the products was seen in their ability to produce antibodies against Herpes simplex virus types 1 and 2, rubella, toxoplasma, cytomegalovirus or tetanus. However, differences in opsonizing antibody were observed between alkylated and native IgG preparations. Peak chemiluminescence responses of neutrophils following opsonization of 2. pneumoniae with native immune globulin were significantly higher than with alkylated IgG, indicating greater functional capacity. These studies suggest that native immune serum globulin provides a greater potential for augmenting host defense mechanisms against pneumococcal infection in hypogammaglobulinemic patients.
LIPOPOLYSACCHARIDE (LPS) STIMULATES HUMAN MACROPHAGES (MO) TO PRODUCE INCREASED
COMPLEMENT (C3). Robert C. Strunk, Kathleen S. Kunke, and F.Sessions Cole, Dept. of Pediatrics, Nat'l. Jewish Hosp. a n d x s . Ctr., Denver, and Children's Hosp. Med. Ctr., Boston.
MO synthesize and secrete small amounts of C3. Studies were designed to determine if C3 production could be stimulated by LPS, a product present a t sites of inflammation. Monocytes separated from normal human peripheral blood were cultured for 7 days in 5% human serum to promote maturation into M 0 3 F 3 production was assessed by hemolytic assay and incorporation of S-methionine into C3 protein. MO cultured in LPS (E.coli 0111: 84-Westphal extraction), 500 nglml, produced more C3 t h a G t r o l s : in 6 experiments increases were 15.1-fold for intracellular pro-C3 protein (range 5.4-32.6), 11.4-fold for extracellular native C3 protein (10.5-13.1), and 10.4-fold for extracellular C3 hernolytic activity (5.1-31.8). In contrast, LPS did not increase production of C2, lysozyme, lactate dehydrogenase, or total protein. Stimulation of C3 production was maximal after 24 hrs exposure to LPS. C3 production was increased by a polysaccharide-free mutant of LPS, but not by alkali-treated LPS, indicating that lipid A was responsible for stimulation. C3 production in human breast milk and bronchoalveolar MO was stimulated by LPS, but production in freshly adherent blood monocytes was not affected. The LPS-stimulated increase in C3 production was cycloheximide inhibitable, suggesting LPS increased translation of C3 protein stimulation. There was no alteration in post-translational processing. This potential for increased C3 synthesis in localized sites of inflammation may be important in resolution of the inflammation process. The humn newborn and irrmunocompromised host a r e p a r t ic u l a r l y susceptible t o t h e devastating e f f e c t s of disseminated VZV and HSV infection. To further investigate t h e relevant i m n e parameters, we developed an ELISA f o r t h e detection of s p e c i f i c AB. P l a s t i c m i c r o t i t e r p l a t e s ( m a t e c h ) ) were t h e s o l i d phase for t h e antigen (Ag) (VZV/HSV antigen -Flow Labs), 100 u l / d e l l of a 1:20 d i l u t i o n i n PBS. Following overnight (O/N) incubation Ag 8s replaced with PBS-gelatin (1 mg/ml) and incubated O/N 4 C. After washing t h r i c e witn PBStween 20 (.05%), t h e index s e r a or c u l t u r e supernates a r e incubated 100 ul/well O/N 4C. Wells a r e washed as above and goat anti-human peroxidase conjugated Ab 1:2000 i n PBS-gelTween-bovine -globulin (5 rng/ml) is incubated 2 hrs. a t room temperature. After washing, s u b s t r a t e 100 ul/ml (ABTS-sigma, 1 mg/ml i n phosphate buffer + .15% H 02) is allowed t o r e a c t a t room temperature and read a t 2 hr2. a t 405 nm ( T i t e r t e k Multiscan The s e n s i t i v i t v of th; method has been useful i n t h e detection of Ab productibn by mononuclear c e l l s i n v i t r o . we-describe a Gocedure of i n v i t r o stimulation and fusion which has produced s i g n i f i c a n t numbers of antigen binding human-human hybridoma antibodies. Twenty t o t h i r t y million mononuclear c e l l s prepared by Ficoll-Hypaque separation of single-cell suspensions of human t o n s i l o r spleen were cultured in the presence of GBS and pokeweed mitogen f o r 2 t o 6 days and then fused with the HGPRT d e f i c i e n t human lymphoblastoid c e l l 1 ine LICR-LON-HMy2.
IMMUNOREGULATORY DEFECTS AND EPSTEIN-BARR VIRUS (EBV)
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IN VITRO SENSITIZATION PRIOR TO FUSION GENERATES
Fused c e l l s were cultured in s e l e c t i v e medium f o r 2 weeks. Growth p o s i t i v e wells observed from t h e 10th t o t h e 30th day following fusion were screened f o r the presence of antibody i n an ELISA o r RIA detecting human antibodies binding t o GBS antigens. Results a r e a s follows:
Fusions Growth Positive Anti-GBS Positive P a t i e n t Performed We1 Recently we reported that the secretion of secretory IgA (SIgA) from human milk leukocytes was stimulated by phagocytosis ( 3 . Infect. Immun. 34: 498, 1981) and certain surface membrane stimuli including N-formyl-L-methionyl-L-phenylalanine (J. Immunol. In Press, 1984) . Since that synthetic peptide is similar to ones secreted by certain strains of enteric bacteria, we questioned whether other bacterial products also trigger the release of that immunoglobulin from phagocytes in human milk. Supernatent fluids from cultures of Escherichia 07KL or Klebsiella pneumoniae obtained by passage through 0 . 2 2~ filters lead to the release of 40-50% of the SIgA found in unfractionated human colostral leukocytes (p<0.01). A similar degree and temporal pattern of SIgA release occurred when those leukocytes were exposed to heat-treated filtrates from those bacterial cultures, purified lipopolysaccharide from E. & or type 1 pili isolated from X. pneumoniae.
Thus, the secretion of SIgA by human milk leukocytes is initiated not only by phagocytosis of intact microorganisms, but also by important components of certain enteric bacterial pathogens. Furthermore, these findings support the hypothesis that SIgA released from those leokocytes plays a role in protecting the breast-fed infant from bacterial infections of the gastrointestinal tract.
